Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2.

[1]  J. Olsen,et al.  Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance , 2001, British journal of haematology.

[2]  S. Markovic,et al.  Acquired C1 Esterase Inhibitor Deficiency , 2000, Annals of Internal Medicine.

[3]  J. Olsen,et al.  Cancer risk in patients with monoclonal gammopathy of undetermined significance , 2000, American journal of hematology.

[4]  R. Kyle,et al.  Monoclonal gammopathies of undetermined significance. , 1999, Hematology/oncology clinics of North America.

[5]  D. Caillaud,et al.  Acquired Angioedema with C1 Inhibitor Deficiency: Is the Distinction between Type I and Type II Still Relevant? , 1999, Dermatology.

[6]  M. Cicardi,et al.  Pathogenetic and clinical aspects of C1 inhibitor deficiency. , 1998, Immunobiology.

[7]  K. Whaley,et al.  Mechanism of Action of Anti-C1-Inhibitor Autoantibodies: Prevention of the Formation of Stable C1s-C1-inh Complexes , 1998, Molecular medicine.

[8]  K. Whaley,et al.  Autoimmune C1‐inhibitor deficiency , 1996, Clinical and experimental immunology.

[9]  M. Cicardi,et al.  Relevance of lymphoproliferative disorders and of anti‐C1 inhibitor autoantibodies in acquired angio‐oedema , 1996, Clinical and experimental immunology.

[10]  G. Arlaud,et al.  C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema. , 1996, The Journal of allergy and clinical immunology.

[11]  K. Whaley,et al.  Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency. , 1996, Journal of immunology.

[12]  R. Kyle.  Monoclonal gammopathy of undetermined significance. , 1994, Blood reviews.

[13]  M. Cicardi,et al.  Autoimmune C1 inhibitor deficiency: report of eight patients. , 1993, The American journal of medicine.

[14]  M. Cicardi,et al.  Hereditary and Acquired C1‐Inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients , 1992, Medicine.

[15]  C. Feighery,et al.  Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema. , 1989, The Journal of clinical investigation.

[16]  J. Alsenz,et al.  Autoantibody-mediated acquired deficiency of C1 inhibitor. , 1987, The New England journal of medicine.

[17]  C. Feighery,et al.  An IgG autoantibody which inactivates C1¯-inhibitor , 1986, Nature.

[18]  A. Sheffer,et al.  Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. , 1985, The New England journal of medicine.

[19]  G. Boss,et al.  Acquired C1 Esterase Inhibitor Deficiency and Angioedema: A Review , 1979, Medicine.

[20]  J. Atkinson,et al.  Hereditary angioedema: the clinical syndrome and its management. , 1976, Annals of internal medicine.

[21]  P. Schur,et al.  Acquired C1 inhibitor deficiency in lymphosarcoma , 1972 .

[22]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[23]  L. Guillou,et al.  Acquired deficiency in C1-inhibitor associated with signet ring cell gastric adenocarcinoma: a probable connection of antitumor-associated antibodies, hemolytic anemia, and complement turnover. , 1995, The Journal of allergy and clinical immunology.

[24]  Davis Rd.  Hereditary and acquired deficiencies of C1 inhibitor. , 1989 .

[25]  A. Davis.  C1 inhibitor and hereditary angioneurotic edema. , 1988, Annual review of immunology.